Watermark
  Back to Search Results

BGB-A317-314

Active, not recruiting

Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-314

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04486391

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20201517

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents